Real-World Evidence Studies For Bio-Identical Hormone Replacement Therapy
October 5, 2023
Real-World Evidence Studies For Bio-Identical Hormone Replacement Therapy
BHRT’s are estimated to account for one third of menopausal hormone therapy prescriptions. However, the debate over safety and efficacy remains vibrant. Similar discussion surrounds BHRT’s for andropause and other male-specific conditions. (See this Article for a deeper review of the topic.) Given their growth and fragmented regulatory environment, BHRT’s are an excellent example of the need for real-world studies.
Dr. Grant Pagdin is utilizing two Circles – one for men and a second for women – to develop BHRT clinical decision support in his practice. Pre-treatment and long-term outcomes assessments include the Cervantes Short-Form Scale and the Aging Males’ Symptom Scale. Aggregated outcomes will be explained and shared with patients, as described on the Outcomes Page on Dr. Pagdin’s website.
Dr. Pagdin’s initial BHRT Circles and associated datasets will focus on standardized outcomes assessments and patient compliance. Subsequent Circles will also collect data on specific types, dosages and other characteristics of bio-identical products used. To learn more, please contact us.
Real-World Evidence Studies For Bio-Identical Hormone Replacement Therapy
October 5, 2023
BHRT’s are estimated to account for one third of menopausal hormone therapy prescriptions. However, the debate over safety and efficacy remains vibrant. Similar discussion surrounds BHRT’s for andropause and other male-specific conditions. (See this Article for a deeper review of the topic.) Given their growth and fragmented regulatory environment, BHRT’s are an excellent example of the need for real-world studies.
Dr. Grant Pagdin is utilizing two Circles – one for men and a second for women – to develop BHRT clinical decision support in his practice. Pre-treatment and long-term outcomes assessments include the Cervantes Short-Form Scale and the Aging Males’ Symptom Scale. Aggregated outcomes will be explained and shared with patients, as described on the Outcomes Page on Dr. Pagdin’s website.
Dr. Pagdin’s initial BHRT Circles and associated datasets will focus on standardized outcomes assessments and patient compliance. Subsequent Circles will also collect data on specific types, dosages and other characteristics of bio-identical products used. To learn more, please contact us.
